Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance
On Aug. 13, 2026, the digital forensics firm reported delays in large transactions and heightened demand for cloud and AI procurement, prompting a leadership change.
Overview
Cellebrite DI (NASDAQ:CLBT), a digital forensics and investigative intelligence software provider, closed at $10.80, down 29.18%. The stock tumbled after Cellebrite cut full-year revenue guidance and reported a quarterly earnings miss. Investors are watching whether the new CEO can stabilize execution and margin trends. Trading volume reached 36.5M shares, coming in about 1355% above its three-month average of 2.5M shares. Cellebrite DI IPO'd in 2020 and has grown 12% since going public.
S&P 500 (SNPINDEX:^GSPC) rose 0.65% to 7,799, and the Nasdaq Composite (NASDAQINDEX:^IXIC) gained 0.82% to 26,805. In digital investigation and intelligence software for law enforcement and enterprise security, Axon Enterprise (NASDAQ:AXON) closed at $615.59, up 2.64%, while NICE (NASDAQ:NICE) finished at $105.25, higher by 6.79%.
Details
Cellebrite grew sales by 16% in Q2, but these figures fell short of analysts’ expectations, while EPS was in line. The real issues for Cellebrite were that management lowered guidance to 19.5% sales growth in Q3 and 15% growth in 2026, and that net income dipped compared to last year.
Source
Originally published at www.fool.com.